And so another day begins. There is much to do this morning. Meanwhile, we wonder if Congress will ever make progress on the FDA reform legislation. Here are a few items to captivate you while we await word from DC....
Alnylam And Merck End Collaboration For RNAi (Yahoo/AP)
Novartis Paid Ricchetti $120K To Lobby Washington (Yahoo/AP)
Merck Plays Catch-Up With Successor To Fosamax (The Star-Ledger of New Jersey)
Teva Wins Expanded Contract With German Health Insurer (Yahoo/Reuters)
Merck KgGA Plans More Takeovers To Boost Sales (Bloomberg News)
Encysive Says Court Dismisses Securities Lawsuit (Yahoo/AP)
Germany's Evotec To Pay $152 Million For Renovis (Yahoo/Reuters)
Abbott Reduces Board To 12 Directors (Yahoo/AP)
Merck's New HIV Drugs Suppressed Virus Through 48 Weeks (Bloomberg News)
Schering-Plough Touts Safety Of AIDS Drug (Bloomberg News)